Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar

被引:1
|
作者
Benkhadra, Maria [1 ]
Elazzazy, Shereen [1 ]
Hamad, Anas Ahmad [1 ]
Elkhatim, Mohamed S. [2 ]
Gulied, Amaal [1 ]
Sahal, Arwa Osama [1 ]
Alasmar, Aya [1 ]
Jibril, Farah I. [1 ]
Afifi, Hebatalla Mahmoud [1 ]
Nasser, Sahar [1 ]
Alnajjar, Afnan [1 ]
Dawoud, Rawan [1 ]
Omar, Nabil E. [1 ,3 ]
机构
[1] Hamad Med Corp, Dept Pharm, Natl Ctr Canc Care & Res, Doha, Qatar
[2] Hamad Med Corp, Dept Med Oncol, Natl Ctr Canc Care & Res, Doha, Qatar
[3] Qatar Univ, Coll Pharm, Clin & Populat Hlth Res, Doha, Qatar
关键词
D O I
10.1182/blood-2023-180648
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
    Hradska, Katarina
    Hajek, Roman
    Jelinek, Tomas
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [32] Clinical characteristics and prognosis of liver injury induced by immune checkpoint inhibitors in patients with malignancies: A real-world retrospective study
    Jiang, Ying
    Lv, Minzhi
    Jin, Zhiping
    Wu, Yi
    Li, Xiaoyu
    Zhang, Ningping
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (11) : 2870 - 2882
  • [33] Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China
    Yang, Yang
    Tan, Lijie
    Hu, Jian
    Li, Yin
    Mao, Yousheng
    Tian, Ziqiang
    Zhang, Baihua
    Ma, Jianqun
    Li, Hecheng
    Chen, Chun
    Chen, Keneng
    Han, Yongtao
    Chen, Longqi
    Liu, Junfeng
    Yu, Bentong
    Yu, Zhentao
    Li, Zhigang
    DISEASES OF THE ESOPHAGUS, 2022, 35 (11)
  • [34] Real-world experience of immune checkpoint inhibitors in patients with solid tumours in the Top End of the Northern Territory, Australia from 2016 to 2021: a retrospective observational cohort study
    Miller, Abigail R.
    Balino, Aries
    Tun Min, Sandy
    Downton, Teesha
    Karanth, Narayan V.
    Backen, Alison
    Charakidis, Michail
    INTERNAL MEDICINE JOURNAL, 2024, 54 (10) : 1652 - 1660
  • [35] Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Kato, Taigo
    Nagahara, Akira
    Kawamura, Norihiko
    Nakata, Wataru
    Soda, Tetsuji
    Matsuzaki, Kyosuke
    Hatano, Koji
    Kawashima, Atsunari
    Ujike, Takeshi
    Imamura, Ryoichi
    Nishimura, Kensaku
    Takada, Shingo
    Tsujihata, Masao
    Yamaguchi, Seiji
    Takao, Tetsuya
    Nakai, Yasutomo
    Nakayama, Masashi
    Nonomura, Norio
    Uemura, Motohide
    ANTICANCER RESEARCH, 2021, 41 (11) : 5811 - 5816
  • [36] Efficacy and safety of immune checkpoint inhibitors in older HCC patients: A real-world study
    Cheng, J.
    Chen, B.
    Lu, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S338 - S338
  • [37] Effect of immune checkpoint inhibitors in metastatic gastric cancer: A real-world evidence study
    Puccetti, F.
    Mazza, E.
    Hernandez-Ibarburu, G.
    Rusconi, F.
    Liscia, N.
    Barbieri, L. A.
    Treppiedi, E.
    Cossu, A.
    Rosati, R.
    Elmore, U.
    ANNALS OF ONCOLOGY, 2023, 34 : S880 - S880
  • [38] Real-world incidence and risk factors of pneumonitis in chemoradiation plus immune checkpoint inhibitors compared with chemoradiation alone in lung cancer: a retrospective cohort study
    Pu, Dan
    Liu, Qing
    Zhang, Shu
    Wang, Liu
    Xu, Feng
    Hofman, Paul
    Giusti, Raffaele
    Zhou, Qinghua
    Li, Xuehan
    Li, Lu
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (01) : 139 - 151
  • [39] Hematologic and lymphatic system toxicities associated with immune checkpoint inhibitors: a real-world study
    Li, Na
    Feng, Yong
    Chen, Xiaoling
    Li, Ye
    Zhang, Chengmiao
    Yin, Yin
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [40] Real-world incidence of immune checkpoint inhibitor-related hepatitis: A single-center retrospective cohort study
    Peterson, A.
    Abasszade, J.
    Bell, S.
    Ratnam, D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 101 - 102